Mizuho Sees Improving Margins Supporting HCA Healthcare into 2026
Mizuho lifted its price target on HCA Healthcare, Inc. (NYSE:HCA) to $520 from $505 on December 18 and kept an Outperform rating as part of its 2026 outlook for managed care and health facilities.





